In corporate news, earnings releases looked mixed. Healthcare stocks could be in demand after drugmakers GSK and Novo Nordisk, and dental-implants maker Straumann all raised their 2022 outlooks. Gains in the sector could be curbed though by a profit warning from hearing-aid maker Demant. 
Positive
Positive
GSK
Positive
Positive
Novo Nordisk
Negative
Negative
Demant
Positive
Positive
Straumann